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Abstract –  The paper discusses the biochemical and physiological 
significance of magnesium. Also, attention is paid to the development 
of lesions related to magnesium deficiency. 
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Streszczenie – Autorzy przedstawili znaczenie biochemiczne i fizjo-
logiczne magnezu. Zwrócili także uwagę na rozwój zmian chorobo-
wych  związanych  z niedoborami magnezu. 
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I. THE BIOCHEMICAL SIGNIFICANCE OF 
MAGNESIUM 
 
agnesium is an important element of organisms. Its con-
tent in respective tissues in human organism is presented  
in Table 1. 
 
 
Table 1. The content of magnesium in selected human 
 tissues [1] 
 
The magnesium con-
tent in: 
Amount Unit 
bone tissue 700-800 ppm 
muscle tissue 900 ppm 
erythrocytes 1,65-2,65 mmol/l 
serum 0,65-1,05 mmol/l 
hair tissue 40-120 ppm 
the organism (total) 20-35 g 
 
The regulative activity of magnesium is basically four-fold: 
 
The participation in energy transformations 
Magnesium is an element required for the synthesis of dif-
ferent compounds with energy-rich bonds, such as ATP (aden-
osine triphosphate), GTP (guanosine triphosphate), UTP (uri-
dine triphosphate), CTP (cytidine triphosphate), ITP (inosine 
triphosphate), with a guanidinium-phosphate bond in w phos-
phocreatine, enol phosphate bond of phosphoenol pyruvic ac-
id, acetyl phosphate bond of 1,3-diphosphoglycerate and the 
bond of thioester acyl-coenzyme A or succinyl-CoA [2-4]. 
Magnesium is also essential to the use of energy-rich 
bonds, which is the case when they undergo hydrolysis or a 
phosphoryl group is transferred [5]. 
 
The role in the respiratory chain 
Magnesium is responsible for the harmony of phosphoryla-
tion processes linked to the chain of oxidation-reduction pro-
cesses. The participation of this bioelement in oxidation-
reduction reactions is related to the formation of phospho-
pyridine nucleotides: DPN (diphosphopyridine nucleotide), 
TPN (triphosphopyridine nucleotide), flavin nucleotides: fla-
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vin mononucleotide (FMN) and  flavin adenine dinucleotide 
(FAD) as well as the formation of coenzyme A [3,4,6]. 
 
The participation in the synthesis and activity of enzymes 
For some enzymes, magnesium can be their integral com-
ponent (e.g. alkaline phosphatase). For most of them, however, 
the bioelement is unstably bonded with an enzyme activator. 
Magnesium ions stimulate over 300 metabolic reactions by 
means of altering the spatial configuration of enzyme active 
centres [2,3,5].  
One of the biologically relevant effects of magnesium ac-
tivity is the activation of the enzymes related to a transfor-
mation in proteins and nucleic acids, such as transferase (nu-
clear transferase), synthetase and kinase.    
The nuclear transferase of RNA participates in RNA (pre-
dominantly tRNA) synthesis. This enzyme, coupled with poly-
ribosome initiation factors and factors prolonging peptide 
chain as well as amino acid-coding polyamines, contributes to 
the formation of proteins, whereas nucleotide transferase in 
DNA allows one to recreate and recombine the DNA [4]. 
 
The regulation of the functioning of cell membranes and 
intracellular organelles 
Magnesium, by means of chelate bonds with cell and orga-
nelle membrane lipids, has impact on their functioning, facili-
tating the transportation of biological substance. 
The bond between magnesium and phospholipids of cell 
membranes decreases their fluidity and permeability, while 
parallel electrostatic polarisation effects take place. In case of 
magnesium deficiency, the permeability of cell membranes 
increases, which leads to electrolyte shifts: the increase of in-
tracellular concentration of Ca 
2+
 and Na
+
 as well as the de-
crease in the K
+
 and phosphor concentration [3,6,7]. 
The changes in the permeability of cell membranes for 
electrolytes caused by the changing magnesium concentration 
are also relevant for the functioning of cell membrane recep-
tors which participate, among others, in neutral transmission 
[8,9]. An example of that are NMDA glutamate receptors 
(stimulated N-Methyl-D-aspartic acid - NMDA). One of the 
most important characteristics of this receptor is the depend-
ence on the block potential on the part of magnesium ions 
(Figure. I).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I. NMDA receptor diagram 
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II. THE AETIOLOGY OF MAGNESIUM 
DEFICIENCY 
 
Magnesium deficiency is always a result of negative bal-
ance, which may be caused by [ 10,11]: 
 An insufficient supply of magnesium in food 
 Insufficient absorption of magnesium from the digestive 
tract caused by, for instance, intestine inflammation or 
the loss of magnesium in bile, gastric or intestinal juice 
(biliary or intestinal fistulas)  
 Excessive magnesium loss in urine caused by a primary 
kidney disease (primary tubulopathy with magnesium 
loss, Bartter syndrome, tubular acidosis, drug-induced 
tubulopathy) 
 Excessive build-up of magnesium in bones (in patients 
who had a parathyroid adenoma removed) or in tissues 
(in cases of acute pancreatitis), the movement of mag-
nesium to cells (in acute patients treated with insulin), 
the loss of magnesium in sweat or milk. 
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The significance of magnesium for the neuromuscular 
system  
The biochemical processes dependent on magnesium pro-
vide the foundations for the functioning of all the organism’s 
organs and systems. However, for some of them – like the neu-
romuscular system – the bioelement is of crucial significance. 
Magnesium deficiency causes limb and tongue tremor, myo-
clonus, Chvostek and Trosseau signs, tetany, muscle weakness, 
paraesthesia, apathy, depression, hallucinations, tremor, dizzi-
ness, nystagmus and sleepiness [1,12,13,14].  
Magnesium deficiency also yield metabolic and cardiovas-
cular symptoms such as: hypocalcaemia insensitive to calcium 
supplementation or sensitive to magnesium, hypokalaemia 
insensitive or hardly sensitive to magnesium, hypersensitivity 
to cardiac glycosides, ventricular cardiac arrhythmia, arterial 
hypertension or coronary insufficiency. Furthermore, magnesi-
um deficiency is believed to have impact on the pathogenesis 
of nephrolithiasis, anaemia, functional disorders of digestive 
tract and osteomalacia [10,11].  
 
 
III. THE PATHOPHYSIOLOGY OF MAGNESIUM 
DEFICIENCY SYMPTOMS 
 
 The cause of neuromuscular symptoms of magnesium defi-
ciency is the intensified acetylcholine release in neural plates, 
which increases the excitability of myocytes and nerve cells. 
The increase in the Ca
2+
 influx to cells and the decrease of K
+
 
and Mg
2+
 ions in those cells lead to the disorders of the resting 
potential and repolarisation of cell membrane. These disorders 
are a cause of hypersensitivity to cardiac glycosides the occur-
rence of dangerous cardiac arrhythmia. Magnesium deficiency 
may also contribute to arterial hypertension (as the Ca
2+
 influx 
to vascular myocytes is increased), coronary insufficiency (in-
creased constriction of coronary vessels) and myocardial in-
farction (the deficiency destabilises the thrombocyte mem-
brane and causes intensified thrombocyte aggregation). Mag-
nesium deficiency may also cause hypercholesterolaemia and 
increased urine lithogenicity. What is more, it may contribute 
to kaliuresis that is resistant to the supplementation of potassi-
um, which leads to hypovolaemia [10,11,14]. 
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Figure II . The aetiology of secondary magnesium defi-
ciency [3,6,7,11] 
 
